Cargando…
Combination Immunotherapy Approaches for Pancreatic Cancer Treatment
Pancreatic ductal adenocarcinoma is a lethal malignant disease with a very low medium survival. Currently, metastatic pancreatic cancer poorly responds to conventional treatments and exhibits an acute resistance to most chemotherapy. Few approaches have been shown to be effective for metastatic panc...
Autores principales: | Cheng, Xianliang, Zhao, Gang, Zhao, Yunqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863289/ https://www.ncbi.nlm.nih.gov/pubmed/29707526 http://dx.doi.org/10.1155/2018/6240467 |
Ejemplares similares
-
Immunotherapy, Radiotherapy, and Hyperthermia: A Combined Therapeutic Approach in Pancreatic Cancer Treatment
por: Mahmood, Javed, et al.
Publicado: (2018) -
Smart Polymeric Nanoparticles in Cancer Immunotherapy
por: Yu, Zhecheng, et al.
Publicado: (2023) -
Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights
por: Kole, Christo, et al.
Publicado: (2022) -
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
por: Liu, Luman, et al.
Publicado: (2022) -
Immunotherapy and Radiation – A New Combined Treatment Approach for Bladder Cancer?
por: Buchwald, Zachary S., et al.
Publicado: (2015)